Aptorum Group Limited (APM) stock soared in the current market. Here is why?
The stock of Aptorum Group Limited (APM) gained in the current market after the company announced that its SACT-1 had been granted an Orphan Drug Designation. APM values at $1.59, gaining more than 30.74% from the previously closed value. At the end of the last trading session, the stock closed at approximately $1.22. The stock […]